A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
about
Acellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Vaccine Adjuvants: from 1920 to 2015 and BeyondPertussis vaccine trials in the 1990sPertussis: Microbiology, Disease, Treatment, and Prevention.Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.Pertussis vaccine: a critique.Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.Vaccine interchangeability.Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.Characterization of co-purified acellular pertussis vaccines.Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL and ADACEL.Pertussis vaccination for health care workers.Pediatric combined formulation DTaP-IPV/Hib vaccine.Review of a new fully liquid, hexavalent vaccine: Hexaxim.Managing a child with possible allergy to vaccine.Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.The Pertussis resurgence: putting together the pieces of the puzzle.Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy.
P2860
Q24193554-0E775905-AEA2-45E2-949C-DBCC2B070CA1Q24201103-D8F54460-DE7B-45FB-BE0D-E9F0CA803473Q24234899-460FD4FF-8183-4D27-8439-31D2F580FAC2Q24243261-D8D9B2FE-3841-41A8-A6D0-A36DC2DEF180Q24522458-7B01CA58-ED7C-4328-A714-9F980B426523Q26783879-74C7D550-4022-45F7-91DE-C3B03E4513D9Q27025393-E4C7DC96-83FE-4391-8441-D4FC089DDD51Q30251684-B2BB3B80-741A-4231-8E98-4B4F66E1BA26Q33156368-6E10E110-F987-4A29-B0A6-4F98CECB8F80Q33521111-0DA90F89-2089-4C72-B785-C8ED83D758D1Q33564283-3B46AA7A-BA9B-41D3-B372-2F364116B160Q33601337-FABFC17B-ACA2-4838-86A3-3198627622DFQ33719897-6F6CB34C-5CFC-4F49-9094-56C73024EAD6Q34657980-026154D3-EEEE-4B52-A0B1-8CE07A5EEC6BQ35046873-E6C4ADCF-6617-4C2A-BE32-D1E70FC66169Q35092870-2C20A2B1-6734-4AE4-BC26-3F7015C0F2FDQ35113522-B957678F-A5AB-4FFF-B200-92FDBCE1C92CQ35887534-70CED36E-1726-4275-8F61-E4788F7A5E16Q36541965-02674A08-D3A0-46E6-88C3-8D6215DAB570Q36803878-EEA55A3A-4D68-445E-ADA9-417BAC22BB61Q37524018-D5FDF251-49C6-4904-8356-9ABA14228439Q38084695-3249BBE6-2772-4753-B1D6-EE8311877946Q38153078-6BB8B0D6-5E44-471F-A387-BF7160FE93BAQ38228975-F5F1D374-E012-47C1-83BF-C0265AF5E577Q40061323-61062E96-CF12-4245-B72E-6EFE0DF356D7Q40281210-10E850DA-03FC-4EF2-9303-470D90285792Q40295958-ABA41E20-50F0-467F-AC51-6CDFBA8EDC1CQ52558356-C90F84C9-C63A-4867-8E6B-96CEF4BC2844Q54288814-18B090B6-878F-4962-9AAF-83E7D195E92B
P2860
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A safety and immunogenicity co ...... 15- to 20-month-old children.
@en
type
label
A safety and immunogenicity co ...... 15- to 20-month-old children.
@en
prefLabel
A safety and immunogenicity co ...... 15- to 20-month-old children.
@en
P2093
P356
P1433
P1476
A safety and immunogenicity co ...... 15- to 20-month-old children.
@en
P2093
Anderson EL
Deforest A
Deloria MA
Edwards KM
Englund JA
Pichichero ME
Rennels MB
Steinhoff MC
P304
P356
10.1542/PEDS.100.5.772
P407
P577
1997-11-01T00:00:00Z